The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
It seems like different people can have lots of different experiences and still receive benefit. And that points to something deeper. It points to the fact that these drugs, which is really what they are, are rewiring neural circuitry in a common way despite a diversity of experience while on the drug.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
psilocybin for its capacity to rewire neural circuits and alleviate depression.
psilocybin can induce neuroplasticity to provide relief for major depression
also the trials on psilocybin are not really about psilocybin they're about neuroplasticity at least the trials for depression right